Also known as: KLOW blend, KLOW peptide
KLOW explainer video
The skin, glow and recovery blends: what GHK-Cu, BPC-157, TB-500 and KPV each bring to the mix.
Under a minute. Education only, not medical advice.
KLOW is GLOW plus one more ingredient. It keeps GHK-Cu, BPC-157 and TB-500 and adds KPV, a three-amino-acid peptide (lysine, proline, valine) that matches the tail end of alpha-MSH, a natural hormone involved in skin pigment and inflammation.
Why people want it: KPV is known in research for calming inflammation. A 2008 study in Gastroenterology found that KPV reduced inflammatory signaling in human intestinal and immune cells and eased colitis in mice. That calming reputation is why KLOW appeals to people who want the full GLOW lineup with an anti-inflammatory angle on top.
What the research says: KPV's evidence is still early, with cell and mouse studies and no published human trials. The other three ingredients carry the same story as GLOW. No study has compared KLOW with GLOW, so whether adding KPV changes results has not been measured.
Status check: KLOW is not an approved medicine. FDA's compounding safety page lists KPV as nominated but withdrawn from Category 2 and notes it has found no human exposure data for KPV products. BPC-157 and TB-500 are prohibited in sport by WADA. Talk with a clinician or dermatologist before trying anything new.
The two halves of the Wolverine stack just won a big vote from an FDA advisory committee. Here is what happened, why it matters, and the White House review that could come next.
RegulationWe have not tested KLOW products yet, so there are no Institute lab results, company rankings or Index Scores on this page. When we do, they will appear here.
Free download
What peptides are, why people are using them, and what results people are talking about, in plain English. Sign up and we email you the Playbook right away.
